Alto Neuroscience, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin 2,688.32%4,446.11%
EBIT Margin 2,759.78%4,989.82%
EBITDA Margin 2,759.78%4,989.82%
Operating Margin 2,759.78%4,989.82%
Net Margin 2,688.32%4,446.11%
FCF Margin 2,475.77%3,599.93%
Leverage & Solvency
Interest Coverage Ratio -27.60-49.90
Times Interest Earned -27.60-49.90
Valuation
Enterprise Value 114.08M
Market Capitalization 114.08M
Return Ratios
Return on Sales 26.88%44.46%